Life Science Leader Magazine

MAR 2014

The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.

Issue link: https://lifescienceleadermag.epubxp.com/i/267232

Contents of this Issue

Navigation

Page 64 of 83

CLINICAL DEVELOPMENT RENAL SITE NETWORK BIOINFORMATICS & ANALYTICS 844.CKD.ESRD (844.253.3773) | FrenovaRenalResearch.com Operating as a Fresenius Medical Care North America company since 2001, Frenova is your only Phase I-IV clinical development partner dedicated exclusively to renal research. No other research partner works with a more intimate understanding of those affected by kidney disease and its comorbid conditions than we do. When you need to conduct a complete renal clinical program, trust the partner that's completely renal — Frenova Renal Research. n Phase I-IV clinical research - Protocol design and feasibility development - Project management - Site selection, start-up, monitoring and auditing - Regulatory services - Central laboratories n 200+ principal investigators n 250+ dialysis research sites n 183,000 active ESRD patients n 390,000 active CKD patients n Historical data on 980,000 dialysis patients and nearly 400,000 CKD patients n Assess protocol feasibility and patient enrollment strategies

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine - MAR 2014